Likuiditas cepet tempesttx.com (TPST)

This price chart illustrates the price action of Tempest Therapeutics (TPST), whose current metric value is 0.37. The company operates within a secure US perimeter, shielded from external political influence. The business relies on patent monetization and licensing agreements for small molecules. Risks are minimized through the development of a pipeline of gastrointestinal and liver therapies in collaboration with global behemoths.

Capital mobility, as reflected by this indicator, is critical for Tempest Therapeutics (TPST) given its focus on oncology development and the search for pharmaceutical partners. It measures the company's ability to settle short-term debts using only cash and accounts receivable while ignoring illiquid inventories, which confirms financial stability and high management proficiency through the prompt coverage of current liabilities.